Basit öğe kaydını göster

An Open-Label, Multinational, Multicenter, Phase IIIb Study with Subcutaneous Administration of Trastuzumab in Patients with HER2-Positive Early Breast Cancer to Evaluate Patient Satisfaction

dc.contributor.authorBelbaraka, Rhizlane
dc.contributor.authorMezlini, Amel
dc.contributor.authorLarbaoui, Blaha
dc.contributor.authorBen Ahmed, Slim
dc.contributor.authorErrihani, Hassan
dc.contributor.authorAlsaleh, Khalid
dc.contributor.authorÖZGÜROĞLU, MUSTAFA
dc.contributor.authorÇİÇİN, İRFAN
dc.contributor.authorGoktas, Burce
dc.contributor.authorYumuk, Perran Fulden
dc.contributor.authorOukkal, Mohammed
dc.contributor.authorMahfouf, Hassen
dc.date.accessioned2022-07-04T14:37:31Z
dc.date.available2022-07-04T14:37:31Z
dc.date.issued2022
dc.identifier.citationÇİÇİN İ., Oukkal M., Mahfouf H., Mezlini A., Larbaoui B., Ben Ahmed S., Errihani H., Alsaleh K., Belbaraka R., Yumuk P. F. , et al., "An Open-Label, Multinational, Multicenter, Phase IIIb Study with Subcutaneous Administration of Trastuzumab in Patients with HER2-Positive Early Breast Cancer to Evaluate Patient Satisfaction", EUROPEAN JOURNAL OF BREAST HEALTH, cilt.18, sa.1, ss.63-73, 2022
dc.identifier.issn2587-0831
dc.identifier.otherav_83fea010-f7f2-4546-b49b-9269e9370b9c
dc.identifier.othervv_1032021
dc.identifier.urihttp://hdl.handle.net/20.500.12627/183537
dc.identifier.urihttps://avesis.istanbul.edu.tr/api/publication/83fea010-f7f2-4546-b49b-9269e9370b9c/file
dc.identifier.urihttps://doi.org/10.4274/ejbh.galenos.2021.2021-9-9
dc.description.abstractObjective: This study was designed to investigate treatment satisfaction in patients and Health Care Professionals (HCP) and to evaluate the safety and tolerability of subcutaneous (SC) trastuzumab in patients with human epidermal growth factor receptor 2 (HER2)-positive early breast cancer (eBC).
dc.language.isoeng
dc.subjectİç Hastalıkları
dc.subjectONKOLOJİ
dc.subjectKlinik Tıp
dc.subjectKlinik Tıp (MED)
dc.subjectTıp
dc.subjectSağlık Bilimleri
dc.subjectDahili Tıp Bilimleri
dc.subjectOnkoloji
dc.subjectOncology
dc.subjectHealth Sciences
dc.titleAn Open-Label, Multinational, Multicenter, Phase IIIb Study with Subcutaneous Administration of Trastuzumab in Patients with HER2-Positive Early Breast Cancer to Evaluate Patient Satisfaction
dc.typeMakale
dc.relation.journalEUROPEAN JOURNAL OF BREAST HEALTH
dc.contributor.departmentTrakya Üniversitesi , ,
dc.identifier.volume18
dc.identifier.issue1
dc.identifier.startpage63
dc.identifier.endpage73
dc.contributor.firstauthorID3397805


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster